Gardasil Use Suggests Need For PDUFA Post-Market Provisions, Senator Says

The use of Merck's human papilloma virus vaccine Gardasil in girls as young as nine years old underscores the need to apply FDA user fee funds to post-marketing surveillance of products, Sen. Barbara Mikulski, D-Md., said during a Senate Health Committee hearing March 14

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet